Moreover, these engineered MM cell-derived exosomes stimulated a type 1 CD4+ T cell response in mice and protected tumor-bearing mice from death through induction of strong CD8+ cytotoxic T lymphocyte (CTL) responses and NK cell-mediated antitumor immunity [144]. The gene discussed is CD8A; the disease is Miyoshi myopathy.